retatrutide type 2 diabetes phase 2 results 2024 2025 🩺 in diabetes: TRANSCEND-T2D-1 3 → HbA1c ↓2.0% + weight ↓16.8% at 40 weeks. A triple agonist that tackles both glycemia and obesity simultaneously. 📊💊 Ref: Lilly Weight loss with retatrutide as

For the latest news, weather, sports, and streaming video, head to NewsNation.

Access to high-quality, powerful weight-loss medications with Noom Med Noom GLP-1 Rx Program, featuring GLP-1 Companion, is designed to maximize your success with medications while helping you develop sustainable habits to live better, longer

Fat loss is especially challenging for women, who face unique hormonal battles

Our subscription model gives you steady program pricing without the uncertainty that comes with insurance-dependent medication costs

That improves pain, but does not by itself prove a direct GLP-1 tissue effect

Patients receiving semaglutide also achieved a whopping 12.5% reduction in their total body weight over the 72-week study period